Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study

被引:0
|
作者
Ariane A. van Loevezijn
Marieke E.M. van der Noordaa
Erik D. van Werkhoven
Claudette E. Loo
Gonneke A. O. Winter-Warnars
Terry Wiersma
Koen K. van de Vijver
Emilie J. Groen
Charlotte F. J. M. Blanken-Peeters
Bas J.G.L. Zonneveld
Gabe S. Sonke
Frederieke H. van Duijnhoven
Marie-Jeanne T. F. D. Vrancken Peeters
机构
[1] Netherlands Cancer Institute - Antoni van Leeuwenhoek,Departments of Surgical Oncology
[2] Netherlands Cancer Institute - Antoni van Leeuwenhoek,Biometrics
[3] Netherlands Cancer Institute - Antoni van Leeuwenhoek,Radiology
[4] Netherlands Cancer Institute - Antoni van Leeuwenhoek,Radiation Oncology
[5] Ghent University Hospital,Department of Pathology
[6] Netherlands Cancer Institute - Antoni van Leeuwenhoek,Pathology
[7] Rijnstate Hospital,Department of Surgical Oncology
[8] Deventer hospital,Department of Radiology
[9] Netherlands Cancer Institute - Antoni van Leeuwenhoek,Medical Oncology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3243 / 3253
页数:10
相关论文
共 50 条
  • [21] Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings
    von Minckwitz, Gunter
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (03) : 779 - 780
  • [22] Artificial intelligence to accurately identify breast cancer patients with a pathologic complete response for omission of surgery after neoadjuvant systemic therapy: An international multicenter analysis.
    Pfob, Andre
    Sidey-Gibbons, Chris
    Tasoulis, Marios Konstantinos
    Lee, Han-Byoel
    Koelbel, Vivian
    Kuerer, Henry Mark
    Heil, Joerg
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Artificial intelligence to accurately identify and select breast cancer patients with a pathologic complete response for omission of surgery after neoadjuvant systemic therapy: an international multicenter analysis
    Pfob, A.
    Sidey-Gibbons, C.
    Tasoulis, M. K.
    Lee, H. B.
    Koelbel, V
    Kuerer, H. M.
    Heil, J.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E88 - E88
  • [24] Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy
    O'Keefe, Thomas J.
    Wallace, Anne M.
    [J]. JAMA SURGERY, 2023, 158 (06) : 674 - 675
  • [25] Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers.
    Myers, Sara P.
    Sevilimedu, Varadan
    Barrio, Andrea Veronica
    Tadros, Audree
    Mamtani, Anita
    Robson, Mark E.
    Morrow, Monica
    Lee, Minna
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial
    Jung, Ji-Jung
    Cheun, Jong-Ho
    Kim, Soo-Yeon
    Koh, Jiwon
    Ryu, Jai Min
    Yoo, Tae-Kyung
    Shin, Hee-Chul
    Ahn, Sung Gwe
    Park, Seho
    Lim, Woosung
    Nam, Sang-Eun
    Park, Min Ho
    Kim, Ku Sang
    Kang, Taewoo
    Lee, Jeeyeon
    Youn, Hyun Jo
    Kim, Yoo Seok
    Yoon, Chang Ik
    Kim, Hong-Kyu
    Moon, Hyeong-Gon
    Han, Wonshik
    Cho, Nariya
    Kim, Min Kyoon
    Lee, Han-Byoel
    [J]. JOURNAL OF BREAST CANCER, 2024, 27 (01) : 61 - 71
  • [27] High pathological grade might discourage early invasive breast cancer patients who have a pathologic complete response to neoadjuvant systemic therapy from eliminating breast surgery
    Li, Chaofan
    Wang, Yusheng
    Liu, Mengjie
    Qu, Jingkun
    Zhang, Shuqun
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (02) : 1268 - 1270
  • [28] Complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis
    Ploumen, Roxanne
    Claassens, Eva
    Kooreman, Loes
    Keymeulen, Kristien
    van Kats, Maartje
    Gommers, Suzanne
    Siesling, Sabine
    van Nijnatten, Thiemo
    Smidt, Marjolein
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [29] Complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis
    Ploumen, R.
    Claassens, E.
    Kooreman, L.
    Keymeulen, K.
    van Kats, M.
    Gommers, S.
    Siesling, S.
    van Nijnatten, T.
    Smidt, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 175 : S1 - S1
  • [30] Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept
    André Pfob
    Lie Cai
    Andreas Schneeweiss
    Geraldine Rauch
    Bettina Thomas
    Benedikt Schaefgen
    Sherko Kuemmel
    Toralf Reimer
    Markus Hahn
    Marc Thill
    Jens-Uwe Blohmer
    John Hackmann
    Wolfram Malter
    Inga Bekes
    Kay Friedrichs
    Sebastian Wojcinski
    Sylvie Joos
    Stefan Paepke
    Tom Degenhardt
    Joachim Rom
    Achim Rody
    Marion van Mackelenbergh
    Maggie Banys-Paluchowski
    Regina Große
    Mattea Reinisch
    Maria Margarete Karsten
    Chris Sidey-Gibbons
    Markus Wallwiener
    Michael Golatta
    Joerg Heil
    [J]. Annals of Surgical Oncology, 2024, 31 : 957 - 965